Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chrysanthemi Indici Flos (CIF) is the inflorescence of *Chrysanthemum indicum L.*, a plant widely utilized in traditional Chinese medicine. It contains various active chemical components, including chlorogenic acid, 3,5-O-dicaffeoylquinic acid, galuteolin, linarin, luteolin, naringenin, kaempferol, and isorhamnetin. CIF demonstrates antioxidant, anti-inflammatory, and antibacterial properties. Its chemical composition and bioactivities are influenced by drying processes, with drier samples exhibiting enhanced antioxidant and anti-inflammatory effects. Research indicates its potential to mitigate inflammation by inhibiting IKKβ activity and suggests antiviral capabilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chrysanthemi Indici Flos.